AI has a major role to play in the great advances to come in biotechnology and human health, from allowing us to explore biology in ways never before possible to accelerating the rate at which we discover and implement new interventions. Learn more about what lies ahead with Anas El Turabi of McKinsey & Company; Jonathan Carlson of Microsoft Health Futures; Mike Nally of Generate Biomedicines and Flagship Pioneering; and NVIDIA's Rory Kelleher as they join Flagship's Armen Mkrtchyan to discuss some of the exciting recent developments in the field of artificial intelligence.

About Flagship Pioneering:
Flagship Pioneering is a biotechnology company that invents and builds platform companies, each with the potential to produce multiple transformative products for human health and sustainable development. Since its launch in 2000, Flagship has initiated and supported more than 100 scientific projects. The current flagship ecosystem includes 44 companies, including Denali Therapeutics, Foghorn Therapeutics, Generate Biomedicines, Inari, Indigo Agriculture, Moderna, Omega Therapeutics, Sana Biotechnology, Seres Therapeutics and Tessera Therapeutics.

Website: www.flagshipioneering.com
Twitter: @FlagshipPioneer
Linkedin: https://www.linkedin.com/company/flagship-pioneering

Please take the opportunity to connect and share this video with your friends and family if you find it useful.